Imprimis Spikes On New Composition Patent For Non-Opioid Sedative
March 27, 2018 at 08:26 AM EDT
Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) announced Tuesday its non-opioid, non-IV sedation formulation, MKO Melt, secured a patent ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.